Ligand validation:2YP9

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2YP9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YP9_NAG_A_1063	22%	64%	0.25	0.868	0.51	0.84	-	-	0	0	100%	0.9333
2YP9_NAG_A_1285	20%	54%	0.247	0.852	0.72	1.05	1	1	0	0	100%	0.9333
2YP9_NAG_A_1038	12%	60%	0.244	0.773	0.38	1.13	-	1	0	0	100%	0.9333
2YP9_NAG_A_1133	6%	50%	0.247	0.683	0.77	1.17	-	1	0	1	100%	0.9333
2YP9_NAG_A_1126	1%	50%	0.413	0.645	0.65	1.27	-	2	0	0	100%	0.9333
4WE8_NAG_A_608	63%	57%	0.152	0.95	0.49	1.14	-	1	0	0	100%	0.9333
2YP2_NAG_A_812	59%	50%	0.115	0.896	0.74	1.18	1	2	0	0	100%	0.9333
4WE9_NAG_A_608	47%	81%	0.158	0.897	0.32	0.5	-	-	0	0	100%	0.9333
4KVN_NAG_A_605	40%	74%	0.155	0.867	0.31	0.67	-	1	0	0	100%	0.9333
2YP7_NAG_A_802	37%	66%	0.211	0.911	0.41	0.88	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.